Liquidia Corporation Common Stock vs NiSource Inc Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.81 (market cap $3.04B), while NiSource Inc Common Stock trades at $41.35 (market cap $19.79B). The key difference: NiSource Inc Common Stock is far larger — about 6.5× Liquidia Corporation Common Stock's market cap, and NiSource Inc Common Stock pays a 2.91% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and NiSource Inc Common Stock for 6 Days on average.
| LQDA | NI | |
|---|---|---|
Market Cap | $3.04B | $19.79B |
Volume | 21,111,778 | 5,778,191 |
Sector | Health | Utilities |
52-Week High | $91.03 | $49.08 |
52-Week Low | $22.02 | $39.00 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $2.94B | $37.12B |
Dividend Yield | — | 2.91% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NiSource (NI) trades at $41.49, up 0.63% today, with a bullish technical signal and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 28, 2026. Fundamentals show solid profitability with a 13.15% net income margin and a P/E of 22.07. Recent news highlights dividend declarations and institutional buying interest, though the stock faces headwinds from storm recovery costs and interest rate sensitivity.
The outlook remains positive given analyst consensus with a $49.57 price target and 73% buy ratings. Key opportunities include data center demand growth and regulatory support, while risks involve volatile cash flows, high debt levels, and potential earnings pressure from operational disruptions. Investors should weigh the stable dividend yield against execution risks in a rising rate environment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →NiSource is an energy holding company whose regulated subsidiaries provide natural gas and electricity services. Its business is organized around gas distribution and electric operations in the United States.
Read more on NI →